Education
About Us
Working with TipRanks
Follow Us
Glenmark Pharmaceuticals Limited (IN:GLENMARK)
:GLENMARK
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ₹ 133.63B | ₹ 126.45B | ₹ 116.56B | ₹ 123.05B | ₹ 109.44B |
| Gross Profit | ₹ 88.38B | ₹ 80.66B | ₹ 72.45B | ₹ 77.57B | ₹ 70.97B |
| Operating Income | ₹ 41.84B | ₹ 33.94B | ₹ 28.11B | ₹ 35.60B | ₹ 29.68B |
| EBITDA | ₹ 21.68B | ₹ 18.30B | ₹ 14.29B | ₹ 19.12B | ₹ 19.45B |
| Net Income | ₹ 10.47B | ₹ -15.02B | ₹ 2.97B | ₹ 9.42B | ₹ 9.70B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ₹ 17.12B | ₹ 16.64B | ₹ 11.73B | ₹ 14.43B | ₹ 11.47B |
| Total Assets | ₹ 160.50B | ₹ 143.59B | ₹ 193.72B | ₹ 170.83B | ₹ 156.04B |
| Total Debt | ₹ 24.73B | ₹ 12.31B | ₹ 46.08B | ₹ 39.62B | ₹ 49.86B |
| Net Debt | ₹ 7.97B | ₹ -4.27B | ₹ 34.49B | ₹ 25.51B | ₹ 38.48B |
| Total Liabilities | ₹ 72.00B | ₹ 65.11B | ₹ 95.32B | ₹ 76.45B | ₹ 85.39B |
| Stockholders' Equity | ₹ 88.49B | ₹ 78.48B | ₹ 94.74B | ₹ 90.87B | ₹ 70.65B |
| Cash Flow | |||||
| Free Cash Flow | ₹ -15.77B | ₹ -11.64B | ₹ 176.29M | ₹ 3.19B | ₹ 3.56B |
| Operating Cash Flow | ₹ -8.28B | ₹ -2.65B | ₹ 6.25B | ₹ 11.09B | ₹ 11.31B |
| Investing Cash Flow | ₹ 20.94M | ₹ 45.44B | ₹ -5.28B | ₹ -3.33B | ₹ -6.75B |
| Financing Cash Flow | ₹ 7.87B | ₹ -39.06B | ₹ -774.56M | ₹ -5.20B | ₹ -4.42B |